These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32929331)

  • 1. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.
    Zhang J; Ying Y; Li M; Wang M; Huang X; Jia M; Zeng J; Ma C; Zhang Y; Li C; Wang X; Shu XS
    Theranostics; 2020; 10(22):10016-10030. PubMed ID: 32929331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
    Romero OA; Vilarrubi A; Alburquerque-Bejar JJ; Gomez A; Andrades A; Trastulli D; Pros E; Setien F; Verdura S; Farré L; Martín-Tejera JF; Llabata P; Oaknin A; Saigi M; Piulats JM; Matias-Guiu X; Medina PP; Vidal A; Villanueva A; Sanchez-Cespedes M
    Nat Commun; 2021 Jul; 12(1):4319. PubMed ID: 34262032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
    Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F
    Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
    Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
    Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
    [No Abstract]   [Full Text] [Related]  

  • 12. Enterotoxigenic
    Liu QQ; Li CM; Fu LN; Wang HL; Tan J; Wang YQ; Sun DF; Gao QY; Chen YX; Fang JY
    Gut Microbes; 2020 Nov; 12(1):1788900. PubMed ID: 32684087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
    Kania AK; Guo M; Scharer CD; Boss JM
    Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
    Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
    Cregan S; Breslin M; Roche G; Wennstedt S; MacDonagh L; Albadri C; Gao Y; O'Byrne KJ; Cuffe S; Finn SP; Gray SG
    Int J Oncol; 2017 Mar; 50(3):1044-1052. PubMed ID: 28197626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
    Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus.
    Montano EN; Bose M; Huo L; Tumurkhuu G; De Los Santos G; Simental B; Stotland AB; Wei J; Bairey Merz CN; Suda J; Martins G; Lalani S; Lawrenson K; Wang Y; Parker S; Venuturupalli S; Ishimori M; Wallace DJ; Jefferies CA
    Arthritis Rheumatol; 2024 Mar; 76(3):396-410. PubMed ID: 37800478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.
    D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J
    Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.